MedPath

Biliary Drainage in Patients With Duodenal Metal Stent

Conditions
Jaundice
Registration Number
NCT02376907
Lead Sponsor
Tokyo University
Brief Summary

This is a retrospective study to evaluate the outcomes of endoscopic biliary drainage according to the timing of distal malignant biliary obstruction (MBO) in relation to gastric outlet obstruction (GOO) and the location of GOO.

Detailed Description

This is a multinational multicenter retrospective cohort study to evaluate the outcomes of endoscopic biliary drainage in patients with a duodenal SEMS. Endoscopic ultrasound-guided biliary drainage (EUS-BD), including choledochoduodenostomy, hepaticogastrostomy, antegrade biliary stenting or a combination, and endoscopic retrograde cholangiopancreatography (ERCP) with stenting are to be compared. Specifically, the outcomes are to be evaluated according to the timing of distal MBO in relation to GOO and the location of GOO.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients who underwent endoscopic placement of a duodenal SEMS for nonresectable malignant GOO.
  • Patients who underwent endoscopic biliary drainage for nonresectable MBO.
  • MBO was located ≥ 2 cm from the bifurcation.
  • Patients who could be followed up more than three months after completion of both biliary drainage and duodenal SEMS placement.
  • Age ≥20 years.
  • Irrespective of sex and a primary disease.
Exclusion Criteria
  • Patients who underwent surgical bypass for GOO.
  • Patients who underwent percutaneous and surgical biliary drainage prior to the placement of duodenal SEMS.
  • Patients with altered gastrointestinal anatomy (Billroth-II reconstruction, Roux-en-Y reconstruction, etc.).
  • Patients who would not give a consent to the report of their own data.
  • Patients considered ineligible for inclusion in the study by an investigator for other reasons.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to recurrent biliary obstructionUp to 1 year

Recurrent biliary obstruction is defined as a composite endpoint of either occlusion or migration of biliary stent, and time to recurrent biliary obstruction is time from biliary drainage to recurrence of biliary obstruction.

Secondary Outcome Measures
NameTimeMethod
Functional success rate of biliary drainage2 weeks

Functional success is defined when bilirubin decreases \< 50% or is normalized within 2 weeks.

Survival timeUp to 2 year

Survival time is defined as the period between biliary stent placement and death.

Causes of recurrent biliary obstructionUp to 1 year

Causes of recurrent biliary obstruction include sludge, food impaction, ingrowth, tumor overgrowth, hemobilia and others.

Procedure-related complication of biliary drainage and duodenal meta stent placement (type and severity)30 days

Complications and their severity are determined using the American Society of Gastrointestinal Endoscopy guidelines.

Trial Locations

Locations (25)

Eastern Hepatobiliary Hospital, Second Military Medical University

🇨🇳

Shanghai, China

The Prince of Wales Hospital

🇭🇰

Shatin, Hong Kong

Asian Institute of Gastroenterology

🇮🇳

Hyderabad, India

Fukushima Medical University

🇯🇵

Fukushima, Japan

Gifu University

🇯🇵

Gifu, Japan

Onomichi General Hospital

🇯🇵

Hiroshima, Japan

Teine-Keijinkai Hospital

🇯🇵

Hokkaido, Japan

Sapporo Medical University

🇯🇵

Hokkaido, Japan

Hokkaido University School of Medicine

🇯🇵

Hokkaido, Japan

Kinki University

🇯🇵

Osaka, Japan

Scroll for more (15 remaining)
Eastern Hepatobiliary Hospital, Second Military Medical University
🇨🇳Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.